SCHEMBL25256589

SCHEMBL25256589

COc1cccc(CN(Cc2cccc(N(C)C)c2)c2ccc(CN3CCN(C)CC3)cc2)c1

nearest known ligand 0.55

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 4/20 0.55
KDM4E B2RXH2 3/20 0.47
ALDH1A1 P00352 3/20 0.47
SMN1; SMN2 Q16637 1/20 0.46
GAA P10253 1/20 0.46
CHKA P35790 1/20 0.46
MAPT P10636 1/20 0.45
TSHR P16473 1/20 0.45
AXL P30530 1/20 0.44
MERTK Q12866 1/20 0.44
MC4R P32245 1/20 0.44
NPC1 O15118 1/20 0.44
TP53 P04637 1/20 0.44
RAB9A P51151 1/20 0.44
HTT P42858 1/20 0.43
FAAH O00519 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30245119 1.00 SIGMAR1 (0.55) SIGMAR1KDM4EALDH1A1SMN1; SMN2GAA
SCHEMBL25253831 0.93 SIGMAR1 (0.57) SIGMAR1KDM4EALDH1A1GAAMAPT
SCHEMBL30245727 0.93 SIGMAR1 (0.57) SIGMAR1KDM4EALDH1A1GAAMAPT
SCHEMBL30245819 0.93 SIGMAR1 (0.63) SIGMAR1KDM4EALDH1A1SMN1; SMN2GAA
SCHEMBL25255754 0.93 SIGMAR1 (0.63) SIGMAR1KDM4EALDH1A1SMN1; SMN2GAA
SCHEMBL25297695 0.91 ALDH1A1 (0.53) SIGMAR1KDM4EALDH1A1SMN1; SMN2GAA
SCHEMBL30245399 0.91 ALDH1A1 (0.53) SIGMAR1KDM4EALDH1A1SMN1; SMN2GAA
SCHEMBL30245208 0.89 SMN1; SMN2 (0.52) SIGMAR1KDM4EALDH1A1SMN1; SMN2GAA
SCHEMBL30245758 0.89 SIGMAR1 (0.63) SIGMAR1KDM4EALDH1A1GAAMAPT
SCHEMBL25248944 0.86 KDM4E (0.57) SIGMAR1KDM4EALDH1A1SMN1; SMN2GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023018472-A9 AMINOARYL-INTEGRIN AGONISTS COMPOUNDS TEXAS HEART INSTITUTE (US) 2023-07-13 WO disclosed